1. Abe T, Sugihara H, Nawa H, Shigemoto R, Mizuno N, Nakanishi S. Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. J Biol Chem 1992;267:13361–13368.

2. Aramori I, Nakanishi S. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron 1992;8:757–765.

3. Bashir ZI, et al. Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature 1993;363: 347–350.

4. Birse EF, et al. Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system. Neuroscience 1993;52:481–488.

5. Bortolotto ZA, Collingridge GL. Activation of glutamate metabotropic receptors induces long-term potentiation. Eur J Pharmacol 1992;214:297–298.

6. Bridges RJ, Lovering FE, Humphrey JM, Stanley, MS, et al. Conformationally restricted inhibitors of the high affinity L-glutamate transporter. Bioorg Med Clem Lett 1993;3:115–121.

7. Bridges RJ, Stanley MS, Anderson MW, Cotman CW, Chamberlin AR. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem 1991;34:717–725.

8. Bridges RJ, Stevens DR, Kahle JS, Nunn PB, Kadri M, Cotman CW. Structure–function studies on N-oxalyl-diamino-dicarboxylic acids and excitatory amino acid receptors: evidence that beta-L-ODAP is a selective non-NMDA agonist. J Neurosci 1989;9:2073–2079.

9. Buller AL, Morrisett RA, Monaghan DT. The NR2 subunit contributes to the pharmacological diversity of native NMDA receptors. Soc Neurosci Abstr 1993;19:1356.

10. Chamberlin AR, Bridges RJ. Conformationally constrained acid amino acids as probes of glutamate receptors and transporters. In: Kozikowski AP, ed. Drug design for neuroscience. New York: Raven Press, 1993;231–259.

11. Chiamulera C, Albertini P, Valerio E, Reggiani A. Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia. Eur J Pharmacol 1992;216:335–336.

12. Choi DW. Excitotoxic cell death. J Neurobiol 1992;23:1261–1276.

13. Cotman CW, Monaghan DT, Ganong AH. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annu Rev Neurosci 1988;11:61–80.

14. Cotman CW, Monaghan DT, Offersen OP, Storm-Mathisen J. Anatomical organization of EAA receptors and their pathways. Trends Neurosci 1987;10:273–280.

15. Durand GM, Gregor P, Zheng X, Bennett MV, Uhl GR, Zukin RS. Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc Natl Acad Sci USA 1992;89:9359–9363.

16. Favaron M, Manev RM, Canedo P, Arban R, et al. Trans-azetidine-2,4-dicarboxylic acid activates neuronal metabotropic receptors. Neuroreport 1993;4:967–970.

17. Fletcher EJ, Mewett KN, Drew CA, Allan RD, Johnston GAR. Inhibition of high affinity L-glutamic acid uptake into rat cortical synaptosomes by the conformationally restricted analogue of glutamic acid: cis-1-aminocyclobutane-1,3-dicarboxylic acid. Neurosci Lett 1991;121:133–135.

18. Hamberger AC, Chiang GH, Nylen ES, Scheff SW, Cotman CW. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate. Brain Res 1979;168:513–530.

19. Hayashi Y, Tanabe Y, Aramori I, Masu M, et al. Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells. Br J Pharmacol 1992;107:539–43.

20. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, et al. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 1993;268:2836–2843.

21. Johansen TH, Drejer J, Watjen F, Nielsen EO. A novel non-NMDA receptor antagonist shows selective displacement of low-affinity [3H]kainate binding. Eur J Pharmacol 1993;246:195–204.

22. Kanai Y, Hediger MA. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 1992;360: 467–471.

23. Kemp JA, Leeson PD. The glycine site of the NMDA receptor—five years on. Trends Pharmacol Sci 1993;14:20–25.

24. Koerner JF, Cotman CW. Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex. Brain Res 1981;216:192–198.

25. Koh JY, Palmer E, Cotman CW. Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. Proc Natl Acad Sci USA 1991;88:9431–9435.

26. Kristensen P, Suzdak PD, Thomsen C. Expression pattern and pharmacology of the rat type IV metabotropic glutamate receptor. Neurosci Lett 1993;155:159–162.

27. Krogsgaard-Larsen P, Nielsen EO, Engfesgaard A, Lauridsen J, Brehm L, Hansen JJ. Amanita muscaria in medicinal chemistry. II. Ibotenic acid analogues as specific agonists at central glutamate receptors. Natural Prod Drug Dev: Alfred Benzen Symp 1984;20: 525–545.

28. Lipartiti M, Fadda E, Savoini G, Siliprandi R, et al. In rats, the metabotropic glutamate receptor-triggered hippocampal neuronal damage is strain-dependent. Life Sci 1993;52:PL85–PL90.

29. Lodge D, Schoepp D. Excitatory amino acids. Trends in Pharmacological Science Receptor Nomenclature Supplement 1993; 4th ed: insert.

30. Martin LJ, Blackstone CD, Huganir RL, Price DL. Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron 1992;9:259–270.

31. Mayer ML, Benveniste M, Patneau DK, Vyklicky LJ. Pharmacologic properties of NMDA receptors. Ann NY Acad Sci 1992;648: 194–204.

32. McDonald JW, Fix AS, Tizzano JP, Schoepp DD. Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist. J Neurosci 1993;13:4445–4455.

33. McGuinness N, Anwyl R, Rowan M. The effects of trans-ACPD on long-term potentiation in the rat hippocampal slice. NeuroReport 1991;2:688–690.

34. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 1989;29:365–402.

35. Monaghan DT, Olverman HJ, Nguyen L, Watkins JC, Cotman CW. Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine. Proc Natl Acad Sci USA 1988;85:9836–9840.

36. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 1991;354:31–37.

37. Nakajima Y, Iwakabe H, Akazawa C, Nawa H, et al. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J Biol Chem 1993;268:11868–11873.

38. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain functions. Science 1992;258:597–603.

39. Nicoletti F, Iadarola MJ, Wroblewski JT, Costa E. Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with a1-adrenoreceptors. Proc Natl Acad Sci USA 1986;83:1931–1935.

40. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 1993;53:1009–1018.

41. Opitz T, Reymann KG. (1S,3R)-ACPD protects synaptic transmission from hypoxia in hippocampal slices. Neuropharmacology 1993;32:103–104.

42. Ortwine DF, Malone TC, Bigge CF, Drummond JT, et al. Generation of N-methyl-D-aspartate agonist and competitive antagonist pharmacophore models. Design and synthesis of phosphonoalkyl-substituted tetrahydroisoquinolines as novel antagonists. J Med Chem 1992;35:1345–1370.

43. Palmer AM, Proctor AW, Stratman GC, Bowen DM. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neurosci Lett 1986;60:199–204.

44. Palmer E, Monaghan DT, Cotman CW. Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor. Eur J Pharmacol 1989;166:585–587.

45. Pellegrini-Giampietro DE, Zukin RS, Bennett MV, Cho S, Pulsinelli WA. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci USA 1992;89:10499–10503.

46. Pin J-P, Waeber C, Prezeau L, Bockaert J, Heineman SF. Alternative splicing generates metabotropic glutamate receptors inducing different patterns of calcium release in Xenopus oocytes. Proc Natl Acad Sci USA 1992;89:10331–10335.

47. Pines G, Danbolt NC, Bjoras M, Bendahan A, et al. Cloning and expression of a rat brain L-glutamate transporter. Nature 1992; 360:464–467.

48. Pizzi M, Fallacara C, Arrighi V, Memo M, Spano PF. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. J Neurochem 1993;61:683–689.

49. Robinson MB, Sinor JD, Dowd LA, Kerwin JF. Subtypes of sodium-dependent high-affinity L-[3H]glutamate transport activity: pharmacologic specificity and regulation by sodium and potassium. J Neurochem 1993;60:167–179.

50. Rogawski MA. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 1993;14:325–331.

51. Rosenberg PA, Amin S, Leitner M. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J Neurosci 1992;12:56–61.

52. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the rat brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992;326:1464–1468.

53. Sacaan AI, Schoepp DD. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neurosci Lett 1992;139:77–82.

54. Schoepp DD, Conn PJ. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 1993;14:13–20.

55. Schousboe A, Larsson P, Krogsgaard-Larsen P, Drejer J, Hertz L. Uptake and release processes for neurotransmitter amino acids in astrocytes. In: Norenberg MD, Hertz L, Schousboe A, eds. The Biochemical Pathology of Astrocytes. New York: Alan R Liss, 1988;381–394.

56. Seeburg PH. The molecular biology of mammalian glutamate receptor channels. Trends Pharmacol Sci 1993;14:297–303.

57. Shank RP, Aprison MH. Present status and significance of the glutamine cycle in CNS tissue. Life Sci 1981;28:837–842.

58. Shigemoto R, Nakanishi S, Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J Comp Neurol 1992;322:121–135.

59. Shinozaki H, Ishida M. Excitatory amino acids: physiological and pharmacological probes for neuroscience research. Acta Neurobiol Exp (Warsz) 1993;53:43–51.

60. Shinozaki H, Ishida M, Shimamoto K, Ohfune Y. Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of glutamate analogue in rat spinal cord. Br J Pharmacol 1989;98:1213–1224.

61. Siliprandi R, Lipartiti M, Fadda E, Sautter J, Manev H. Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity. Eur J Pharmacol 1992;219:173–174.

62. Sommer B, Keinanen K, Verdoorn TA, Wisdem W, et al. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 1990;249:1580–1585.

63. Staubli U, Rogers G, Lynch G. Facilitation of glutamate receptors enhances memory. Proc Natl Acad Sci USA 1994;91:777–781.

64. Stewart GR, Zorumski CF, Price MT, Olney JT. Domoic acid: a dementia-inducing excitotoxic food poison with kainic acid receptor specificity. Exp Neurol 1990;110:127–138.

65. Storck T, Schulte S, Hofmann K, Stoffel W. Structure, expression, and functional analysis of a Na+-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 1992;89:10955–10959.

66. Tanabe Y, Masu M, Ishii T, Shigemoto R, Nakanishi S. A family of metabotropic glutamate receptors. Neuron 1992;8:169–179.

67. Tanabe Y, Nomura A, Masu M, Shigemoto R, Mizuno N, Nakanishi S. Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic receptors, mGluR3 and mGluR4. J Neurosci 1993;13:1372–1378.

68. Tang C-M, Shi Q-Y, Katchman A, Lynch G. Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science 1991;254:288–290.

69. Thomsen C, Kristensen P, Mulvihill E, Haldeman B, Suzdak PD. L-2-Amino-4-phosphonobutyrate (L-AP4) is an agonist at the IV metabotropic glutamate receptor which is negatively coupled to adenylate cyclase. Eur J Pharmacol Mol Pharmacol Section 1992;227:362–362.

70. Thomson AM. A magnesium-sensitive post-synaptic potential in rat cerebral cortex resembles neuronal responses to N-methylaspartate. J Physiol 1986;370:531–549.

71. Uhl GR. Neurotransmitter transporters: a promising new gene family. Trends Neurosci 1992;15:265–268.

72. Yamada KA, Tang C. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J Neurosci 1993;13:3904–3915.

Back to Chapter